Arine vs TailorMed
Both address why patients do not take their medicines, and they answer different halves of it. Arine works the clinical half for health plans, ingesting clinical, socioeconomic and behavioural data across a membership to find people whose regimen is failing them, with HITRUST at the risk based tier and named client results. TailorMed works the financial half for providers and pharmacies, finding at risk patients and matching them to assistance so the medicine is affordable in the first place. A patient can be perfectly identified by one and still not fill the prescription for reasons the other addresses. Both report self measured savings, and neither publishes subgroup performance, which matters because both decide who gets helped.
- It ingests clinical, socioeconomic and behavioural data across a plan's membership to find members at risk before an event, with HITRUST at the risk based tier.
- Results are named to real clients with quantified savings per engaged member, which is more commercial specificity than most vendors here provide.
- The buyer is the plan, so the workflow and contracting are shaped for population level medication management.
- It identifies financially at risk patients and matches them to assistance programmes, which is provider side work aimed at the patient's ability to pay.
- The incentive is aligned with the patient affording their care rather than with a savings figure reported to a plan.
- Financial navigation reaches across therapies and payers rather than optimising one membership.
Side by Side
| Axis | A Arine |
T TailorMed |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Value Based Care Intelligence page.
Both vendors sell outcomes measured by the party being paid for them, and the savings figures on either side are self reported, so ask for the denominator, the comparison group and who computed the result. Neither publishes a subgroup analysis, and in medication management that gap matters twice over: a model that decides who gets a pharmacist intervention and a workflow that decides who is offered financial assistance both fail quietly for the populations they reach least well. Neither publishes pricing.